The latest: Hotelier H World Group Ltd. (HTHT.US; 1179.HK) on Tuesday announced it will raise $260 million by selling 6.19 million American depositary shares (ADSs), or about 1.95% of its enlarged share capital, at a price of $42 each.

Looking up: H World will use the funds to enhance the competitiveness of its hotel portfolio and develop its regional-based operating model in the post-Covid era, as well as for investing in technology infrastructure and its supply chain ecosystem.

Take Note: The sale price represents a 4% discount to H World’s closing price the day before the announcement, indicating tepid demand for the shares. H World added the deal is also subject to market and other closing conditions.

Digging Deeper: H World is a China-based hotel group with nearly 800,000 rooms in 8,402 hotels both inside and outside China at the end of September. The company’s low-cost Hanting chain is the backbone of its business, and it operates higher-end brands like Mercure, Ibis and Ibis Styles in China through a strategic partnership with France’s Accor (AC.PA). The company’s revenue grew 16% year-on-year in last year’s third quarter and is expected to grow 7% to 11% in the fourth quarter, benefiting from the start of a tourism recovery in the non-China international markets where H World does business.

Market Reaction: H World’s New York-listed shares rose 0.89% on Tuesday after the announcement. But its Hong Kong-listed shares dropped on Wednesday to close down 0.7% at HK$35.10 by the midday break. They now trade at the upper end of their 52-week range.

Translation by Jony Ho

To subscribe to Bamboo Works free weekly newsletter, click here

Recent Articles

Momenta approved for U.S. listing

Momenta accelerates its drive towards U.S. listing

The company is the latest from China’s increasingly crowded autonomous driving technology sector to seek funds from an overseas IPO Key Takeaways: China’s securities regulator has approved Momenta's plan for…
Yidu's algorithims cleared by CAC

Yidu finds good medicine in regulatory nod for its AI

The provider of medical big data services said China’s cyber regulator recently approved two of its key deep synthesis algorithms Key Takeaways: Yidu Tech’s shares rose 13.6% on the day…